[1]
H. Ahmed, A. I. Abushouk, M. Gadelkarim, A. Mohamed, M. Gabr, and A. Negida, “Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection”, Bangladesh J Pharmacol, vol. 12, no. 1, pp. 12–22, Mar. 2017.